TEST BANK - PHARMACOLOGY : A PATIENT-
CENTERED NURSING PROCESS APPROACH 12TH
EDITION ( LINDA E. MCCUISTION, 2025) ALL
CHAPTERS | NEWEST EDITION
,TABLE OF CONTENTS
Chapter 01: Drug Development and Ethical Considerations
Chapter 02: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Chapter 03: Cultural Considerations Chapter 04: Complementary and Alternative
Therapies
Chapter 05: Pediatric Considerations Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use Disorder
Chapter 08: The Nursing Process and Patient-Centered Care
Chapter 09: Safety and Quality Chapter 10: Drug Administration Chapter 11:
Drug Calculations Chapter 12: Fluid Volume and Electrolytes
Chapter 13: Vitamin and Mineral Replacement
Chapter 14: Nutritional Support Chapter 15: Adrenergic Agonists and
Antagonists
Chapter 16: Cholinergic Agonists and Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants Chapter 19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms Chapter 22:
Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and Mood Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
,Chapter 27: Antituberculars, Antifungals, and Antivirals
Anthelmintic
Chapter 29: HIV- and AIDS-Related Drugs
Chapter 30: Transplant Drugs Chapter 31: Vaccines Chapter 32: Anticancer Drugs
Chapter 33: Targeted Therapies to Treat Cancer
Chapter 34: Biologic Response Modifiers
Chapter 35: Upper Respiratory Disorders
Chapter 36: Lower Respiratory Disorders
Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics Chapter 38:
Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics Chapter 41:
Antihyperlipidemics and Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract Disorders
Chapter 43: Antiulcer Drugs Chapter 44: Eye and Ear Disorders Chapter 45:
Dermatologic Disorders Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal
Disorders Chapter 47: Antidiabetics
Chapter 48: Urinary Disorders Chapter 49: Pregnancy and Preterm Labor
Chapter 50: Labor, Delivery, and Postpartum
Chapter 51: Neonatal and Newborn Chapter 52: Women's Reproductive Health
Chapter 53: Men's Reproductive Health Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the
contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a portion of a
drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic form.
The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the trademark
name and is always capitalized. The chemical name describes the chemical structure of the drug.
CENTERED NURSING PROCESS APPROACH 12TH
EDITION ( LINDA E. MCCUISTION, 2025) ALL
CHAPTERS | NEWEST EDITION
,TABLE OF CONTENTS
Chapter 01: Drug Development and Ethical Considerations
Chapter 02: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Chapter 03: Cultural Considerations Chapter 04: Complementary and Alternative
Therapies
Chapter 05: Pediatric Considerations Chapter 06: Geriatric Considerations
Chapter 07: Drugs in Substance Use Disorder
Chapter 08: The Nursing Process and Patient-Centered Care
Chapter 09: Safety and Quality Chapter 10: Drug Administration Chapter 11:
Drug Calculations Chapter 12: Fluid Volume and Electrolytes
Chapter 13: Vitamin and Mineral Replacement
Chapter 14: Nutritional Support Chapter 15: Adrenergic Agonists and
Antagonists
Chapter 16: Cholinergic Agonists and Antagonists
Chapter 17: Stimulants
Chapter 18: Depressants Chapter 19: Antiseizure Drugs
Chapter 20: Drugs for Parkinsonism and Alzheimer's Disease
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms Chapter 22:
Antipsychotics and Anxiolytics
Chapter 23: Antidepressants and Mood Stabilizers
Chapter 24: Antiinflammatories
Chapter 25: Analgesics
Chapter 26: Antibacterials
,Chapter 27: Antituberculars, Antifungals, and Antivirals
Anthelmintic
Chapter 29: HIV- and AIDS-Related Drugs
Chapter 30: Transplant Drugs Chapter 31: Vaccines Chapter 32: Anticancer Drugs
Chapter 33: Targeted Therapies to Treat Cancer
Chapter 34: Biologic Response Modifiers
Chapter 35: Upper Respiratory Disorders
Chapter 36: Lower Respiratory Disorders
Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics Chapter 38:
Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics Chapter 41:
Antihyperlipidemics and Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract Disorders
Chapter 43: Antiulcer Drugs Chapter 44: Eye and Ear Disorders Chapter 45:
Dermatologic Disorders Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal
Disorders Chapter 47: Antidiabetics
Chapter 48: Urinary Disorders Chapter 49: Pregnancy and Preterm Labor
Chapter 50: Labor, Delivery, and Postpartum
Chapter 51: Neonatal and Newborn Chapter 52: Women's Reproductive Health
Chapter 53: Men's Reproductive Health Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
, Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the
contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box. ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a portion of a
drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application) TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic form.
The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary. ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the trademark
name and is always capitalized. The chemical name describes the chemical structure of the drug.
